Amarin | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amarin USD 162.41M 17.54M 2025-03
AstraZeneca USD 33.54B 4.41B 2025-06
DBV Technologies USD 40.38M 9.25M 2025-03
GlaxoSmithKline GBP 20.38B 453M 2025-06
Halozyme Therapeutics USD 134.28M 16.1M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 31.71B 95M 2025-06


Amarin Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.